Caffeine and Cerebrovascular Reactivity

NCT04730193 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Caffeine

Interventions

DRUG: Caffeine
DRUG: Placebo

Sponsor

University of Oklahoma